GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (OTCPK:BRAXF) » Definitions » Net Change in Cash

Braxia Scientific (Braxia Scientific) Net Change in Cash : $-1.02 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Braxia Scientific's Net Change in Cash for the three months ended in Dec. 2023 was $-0.43 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.02 Mil.

Braxia Scientific Net Change in Cash Historical Data

The historical data trend for Braxia Scientific's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific Net Change in Cash Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
Net Change in Cash
6.40 -1.91 -5.27

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.71 -0.02 -0.45 -0.11 -0.43

Braxia Scientific Net Change in Cash Calculation

Braxia Scientific's Net Change in Cash for the fiscal year that ended in Mar. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-5.407+-0.824+0.903+0.056
=-5.27

Braxia Scientific's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.397+-0.007+-0.032+0.002
=-0.43

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Braxia Scientific Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Braxia Scientific (Braxia Scientific) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (OTCPK:BRAXF) » Definitions » Net Change in Cash
Comparable Companies
XCNQ:MBIO XCNQ:NOVA TSX:APLI TSXV:IOT XCNQ:MESC XCNQ:BIOV XCNQ:GLOW TSXV:RP TSXV:MRVL TSX:IPCI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
4960:Germany 4960:Germany BRAX:Canada
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Website
https://www.braxiascientific.com
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (Braxia Scientific) Headlines

From GuruFocus

Braxia Scientific to Present at H.C. Wainwright Global Investment Conference, Miami from May 24-26, 2022

By PRNewswire PRNewswire • 07-08-2022

Braxia Scientific to Present at H.C. Wainwright Global Investment Conference, Miami from May 24-26, 2022

By PRNewswire PRNewswire • 06-08-2022

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America

By PRNewswire PRNewswire • 11-30-2022

Glancy Prongay & Murray LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Champignon Brands Inc. n/k/a Braxia Scientific Corp. shares - BRAXF

By Value_Insider Value_Insider • 12-14-2022

Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-Assisted Therapy for Depression in Ontario

By PRNewswire PRNewswire • 07-09-2022

Braxia Scientific Presents Positive Preliminary Findings from Phase II Randomized, Multi-Dose Clinical Trial of Psilocybin-Assisted Therapy for Treatment Resistant Depression

By PRNewswire PRNewswire • 06-22-2022

Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.

By PRNewswire PRNewswire • 08-03-2022

Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth

By PRNewswire PRNewswire • 07-27-2022

Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-Assisted Therapy for Depression in Ontario

By PRNewswire PRNewswire • 06-29-2022

Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry

By PRNewswire PRNewswire • 06-27-2022